MedPath

Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers

Completed
Conditions
Hepatitis C, Chronic
Hepatitis C
Registration Number
NCT03038763
Lead Sponsor
University of Pennsylvania
Brief Summary

The investigators aim to determine the prevalence of hepatitis C in the adult children of female baby boomers. During the years baby boomers were becoming pregnant, hepatitis C testing was either not available or was not standard of care. Because of this, participants' children may be unaware of participants' risk of hepatitis C.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria

Mothers:

  • Born between 1/1/45-12/31/64
  • Black or white race
  • Active or prior infection with hepatitis C
  • Have at least one living adult child over the age of 18

Children:

  • ≥18 years of age
  • Born to mother with current or prior HCV infection, with likely timing of HCV acquisition prior to or during pregnancy
  • Mother gave informed consent for child to be approached for study participation
Exclusion Criteria

Mothers:

  • Unwilling to disclose hepatitis C status to children

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HCV prevalenceWithin 1 week of labwork at first study visit

Prevalence of HCV in adult children of female baby boomers who have or have had HCV

Secondary Outcome Measures
NameTimeMethod
Liver fibrosisWithin 2 weeks of diagnosis of HCV

Level of liver fibrosis (detected through fibrosure test) found in adult children diagnosed as HCV-positive

HCV genotypeWithin 6 weeks of diagnosis of HCV

HCV genotype for adult children diagnosed as HCV-positive

Trial Locations

Locations (1)

Perelman Center for Advanced Medicine

🇺🇸

Philadelphia, Pennsylvania, United States

Perelman Center for Advanced Medicine
🇺🇸Philadelphia, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.